APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Immune Health Ingredient

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Immune Health Ingredient Market Analysis and Forecast 2026-2032

Report ID 174001930222 December 2025200 pages

Choose your research edition.

Industry ResearchImmune Health Ingredient Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Health Ingredient Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Immune Health Ingredient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Health Ingredient Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Health Ingredient Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Immune Health Ingredient market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immune Health Ingredient is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Immune Health Ingredient is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Immune Health Ingredient is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Immune Health Ingredient is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Immune Health Ingredient include ADM, Arla Foods, Associated British Foods, Balchem, Cargill, Chr. Hansen, Divis Laboratories, DSM and Glanbia PLC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Immune Health Ingredient, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Immune Health Ingredient, also provides the sales of main regions and countries. Of the upcoming market potential for Immune Health Ingredient, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immune Health Ingredient sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immune Health Ingredient market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Immune Health Ingredient sales, projected growth trends, production technology, application and end-user industry.

Immune Health Ingredient Segment by Company

ADM

Arla Foods

Associated British Foods

Balchem

Cargill

Chr. Hansen

Divis Laboratories

DSM

Glanbia PLC

Ingredion

International Flavors & Fragrances

Kerry Group PLC

MartinBauer

Roquette

ROYAL FRIESLANDCAMPINA N.V.

Tate & Lyle

BASF

Fonterra

Lonza

Probi

Immune Health Ingredient Segment by Type

Plant & Fruit Extracts

Nutritional Lipids

Prebiotics

Probiotic Starter Cultures

Vitamins

Minerals

Enzymes

Functional Carbohydrates

Proteins

Immune Health Ingredient Segment by Application

Beverages

Pharmaceuticals

Feed

Food

Others

Immune Health Ingredient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Health Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Ingredient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Immune Health Ingredient in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Immune Health Ingredient manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Health Ingredient sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immune Health Ingredient Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Plant & Fruit Extracts Major Manufacturers Table 3. Nutritional Lipids Major Manufacturers Table 4. Prebiotics Major Manufacturers Table 5. Probiotic Starter Cultures Major Manufacturers Table 6. Vitamins Major Manufacturers Table 7. Minerals Major Manufacturers Table 8. Enzymes Major Manufacturers Table 9. Functional Carbohydrates Major Manufacturers Table 10. Proteins Major Manufacturers Table 11. Global Immune Health Ingredient Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 12. Beverages Major Manufacturers Table 13. Pharmaceuticals Major Manufacturers Table 14. Feed Major Manufacturers Table 15. Food Major Manufacturers Table 16. Others Major Manufacturers Table 17. Immune Health Ingredient Industry Trends Table 18. Immune Health Ingredient Industry Drivers Table 19. Immune Health Ingredient Industry Opportunities and Challenges Table 20. Immune Health Ingredient Industry Restraints Table 21. Global Immune Health Ingredient Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global Immune Health Ingredient Revenue by Region (2021-2026) & (US$ Million) Table 23. Global Immune Health Ingredient Revenue by Region (2027-2032) & (US$ Million) Table 24. Global Immune Health Ingredient Revenue Market Share by Region (2021-2026) Table 25. Global Immune Health Ingredient Revenue Market Share by Region (2027-2032) Table 26. Global Immune Health Ingredient Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 27. Global Immune Health Ingredient Sales by Region (2021-2026) & (k units) Table 28. Global Immune Health Ingredient Sales by Region (2027-2032) & (k units) Table 29. Global Immune Health Ingredient Sales Market Share by Region (2021-2026) Table 30. Global Immune Health Ingredient Sales Market Share by Region (2027-2032) Table 31. Global Immune Health Ingredient Revenue by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Immune Health Ingredient Revenue Market Share by Manufacturers (2021-2026) Table 33. Global Immune Health Ingredient Sales by Manufacturers (US$ Million) & (2021-2026) Table 34. Global Immune Health Ingredient Sales Market Share by Manufacturers (2021-2026) Table 35. Global Immune Health Ingredient Sales Price (US$/unit) of Manufacturers (2021-2026) Table 36. Global Immune Health Ingredient Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 37. Global Immune Health Ingredient Key Manufacturers Manufacturing Sites & Headquarters Table 38. Global Immune Health Ingredient Manufacturers, Product Type & Application Table 39. Global Immune Health Ingredient Manufacturers' Establishment Date Table 40. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 41. Global Immune Health Ingredient by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Immune Health Ingredient Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Immune Health Ingredient Revenue by Type (2021-2026) & (US$ Million) Table 44. Global Immune Health Ingredient Revenue by Type (2027-2032) & (US$ Million) Table 45. Global Immune Health Ingredient Revenue Market Share by Type (2021-2026) Table 46. Global Immune Health Ingredient Revenue Market Share by Type (2027-2032) Table 47. Global Immune Health Ingredient Sales by Type 2021 VS 2025 VS 2032 (k units) Table 48. Global Immune Health Ingredient Sales by Type (2021-2026) & (k units) Table 49. Global Immune Health Ingredient Sales by Type (2027-2032) & (k units) Table 50. Global Immune Health Ingredient Sales Market Share by Type (2021-2026) Table 51. Global Immune Health Ingredient Sales Market Share by Type (2027-2032) Table 52. Global Immune Health Ingredient Price by Type (2021-2026) & (US$/unit) Table 53. Global Immune Health Ingredient Price by Type (2027-2032) & (US$/unit) Table 54. Global Immune Health Ingredient Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Immune Health Ingredient Revenue by Application (2021-2026) & (US$ Million) Table 56. Global Immune Health Ingredient Revenue by Application (2027-2032) & (US$ Million) Table 57. Global Immune Health Ingredient Revenue Market Share by Application (2021-2026) Table 58. Global Immune Health Ingredient Revenue Market Share by Application (2027-2032) Table 59. Global Immune Health Ingredient Sales by Application 2021 VS 2025 VS 2032 (k units) Table 60. Global Immune Health Ingredient Sales by Application (2021-2026) & (k units) Table 61. Global Immune Health Ingredient Sales by Application (2027-2032) & (k units) Table 62. Global Immune Health Ingredient Sales Market Share by Application (2021-2026) Table 63. Global Immune Health Ingredient Sales Market Share by Application (2027-2032) Table 64. Global Immune Health Ingredient Price by Application (2021-2026) & (US$/unit) Table 65. Global Immune Health Ingredient Price by Application (2027-2032) & (US$/unit) Table 66. ADM Company Information Table 67. ADM Business Overview Table 68. ADM Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. ADM Immune Health Ingredient Product Portfolio Table 70. ADM Recent Development Table 71. Arla Foods Company Information Table 72. Arla Foods Business Overview Table 73. Arla Foods Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Arla Foods Immune Health Ingredient Product Portfolio Table 75. Arla Foods Recent Development Table 76. Associated British Foods Company Information Table 77. Associated British Foods Business Overview Table 78. Associated British Foods Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Associated British Foods Immune Health Ingredient Product Portfolio Table 80. Associated British Foods Recent Development Table 81. Balchem Company Information Table 82. Balchem Business Overview Table 83. Balchem Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Balchem Immune Health Ingredient Product Portfolio Table 85. Balchem Recent Development Table 86. Cargill Company Information Table 87. Cargill Business Overview Table 88. Cargill Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Cargill Immune Health Ingredient Product Portfolio Table 90. Cargill Recent Development Table 91. Chr. Hansen Company Information Table 92. Chr. Hansen Business Overview Table 93. Chr. Hansen Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Chr. Hansen Immune Health Ingredient Product Portfolio Table 95. Chr. Hansen Recent Development Table 96. Divis Laboratories Company Information Table 97. Divis Laboratories Business Overview Table 98. Divis Laboratories Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Divis Laboratories Immune Health Ingredient Product Portfolio Table 100. Divis Laboratories Recent Development Table 101. DSM Company Information Table 102. DSM Business Overview Table 103. DSM Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. DSM Immune Health Ingredient Product Portfolio Table 105. DSM Recent Development Table 106. Glanbia PLC Company Information Table 107. Glanbia PLC Business Overview Table 108. Glanbia PLC Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Glanbia PLC Immune Health Ingredient Product Portfolio Table 110. Glanbia PLC Recent Development Table 111. Ingredion Company Information Table 112. Ingredion Business Overview Table 113. Ingredion Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Ingredion Immune Health Ingredient Product Portfolio Table 115. Ingredion Recent Development Table 116. International Flavors & Fragrances Company Information Table 117. International Flavors & Fragrances Business Overview Table 118. International Flavors & Fragrances Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. International Flavors & Fragrances Immune Health Ingredient Product Portfolio Table 120. International Flavors & Fragrances Recent Development Table 121. Kerry Group PLC Company Information Table 122. Kerry Group PLC Business Overview Table 123. Kerry Group PLC Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Kerry Group PLC Immune Health Ingredient Product Portfolio Table 125. Kerry Group PLC Recent Development Table 126. MartinBauer Company Information Table 127. MartinBauer Business Overview Table 128. MartinBauer Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. MartinBauer Immune Health Ingredient Product Portfolio Table 130. MartinBauer Recent Development Table 131. Roquette Company Information Table 132. Roquette Business Overview Table 133. Roquette Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Roquette Immune Health Ingredient Product Portfolio Table 135. Roquette Recent Development Table 136. ROYAL FRIESLANDCAMPINA N.V. Company Information Table 137. ROYAL FRIESLANDCAMPINA N.V. Business Overview Table 138. ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Product Portfolio Table 140. ROYAL FRIESLANDCAMPINA N.V. Recent Development Table 141. Tate & Lyle Company Information Table 142. Tate & Lyle Business Overview Table 143. Tate & Lyle Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Tate & Lyle Immune Health Ingredient Product Portfolio Table 145. Tate & Lyle Recent Development Table 146. BASF Company Information Table 147. BASF Business Overview Table 148. BASF Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. BASF Immune Health Ingredient Product Portfolio Table 150. BASF Recent Development Table 151. Fonterra Company Information Table 152. Fonterra Business Overview Table 153. Fonterra Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Fonterra Immune Health Ingredient Product Portfolio Table 155. Fonterra Recent Development Table 156. Lonza Company Information Table 157. Lonza Business Overview Table 158. Lonza Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Lonza Immune Health Ingredient Product Portfolio Table 160. Lonza Recent Development Table 161. Probi Company Information Table 162. Probi Business Overview Table 163. Probi Immune Health Ingredient Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Probi Immune Health Ingredient Product Portfolio Table 165. Probi Recent Development Table 166. North America Immune Health Ingredient Revenue by Type (2021-2026) & (US$ Million) Table 167. North America Immune Health Ingredient Revenue by Type (2027-2032) & (US$ Million) Table 168. North America Immune Health Ingredient Sales by Type (2021-2026) & (k units) Table 169. North America Immune Health Ingredient Sales by Type (2027-2032) & (k units) Table 170. North America Immune Health Ingredient Sales Price by Type (2021-2026) & (US$/unit) Table 171. North America Immune Health Ingredient Sales Price by Type (2027-2032) & (US$/unit) Table 172. North America Immune Health Ingredient Revenue by Application (2021-2026) & (US$ Million) Table 173. North America Immune Health Ingredient Revenue by Application (2027-2032) & (US$ Million) Table 174. North America Immune Health Ingredient Sales by Application (2021-2026) & (k units) Table 175. North America Immune Health Ingredient Sales by Application (2027-2032) & (k units) Table 176. North America Immune Health Ingredient Sales Price by Application (2021-2026) & (US$/unit) Table 177. North America Immune Health Ingredient Sales Price by Application (2027-2032) & (US$/unit) Table 178. North America Immune Health Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. North America Immune Health Ingredient Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. North America Immune Health Ingredient Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. North America Immune Health Ingredient Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 182. North America Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 183. North America Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 184. North America Immune Health Ingredient Sales Price by Country (2021-2026) & (US$/unit) Table 185. North America Immune Health Ingredient Sales Price by Country (2027-2032) & (US$/unit) Table 186. United States Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 187. Canada Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 188. Mexico Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 189. Europe Immune Health Ingredient Revenue by Type (2021-2026) & (US$ Million) Table 190. Europe Immune Health Ingredient Revenue by Type (2027-2032) & (US$ Million) Table 191. Europe Immune Health Ingredient Sales by Type (2021-2026) & (k units) Table 192. Europe Immune Health Ingredient Sales by Type (2027-2032) & (k units) Table 193. Europe Immune Health Ingredient Sales Price by Type (2021-2026) & (US$/unit) Table 194. Europe Immune Health Ingredient Sales Price by Type (2027-2032) & (US$/unit) Table 195. Europe Immune Health Ingredient Revenue by Application (2021-2026) & (US$ Million) Table 196. Europe Immune Health Ingredient Revenue by Application (2027-2032) & (US$ Million) Table 197. Europe Immune Health Ingredient Sales by Application (2021-2026) & (k units) Table 198. Europe Immune Health Ingredient Sales by Application (2027-2032) & (k units) Table 199. Europe Immune Health Ingredient Sales Price by Application (2021-2026) & (US$/unit) Table 200. Europe Immune Health Ingredient Sales Price by Application (2027-2032) & (US$/unit) Table 201. Europe Immune Health Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. Europe Immune Health Ingredient Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. Europe Immune Health Ingredient Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. Europe Immune Health Ingredient Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 205. Europe Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 206. Europe Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 207. Europe Immune Health Ingredient Sales Price by Country (2021-2026) & (US$/unit) Table 208. Europe Immune Health Ingredient Sales Price by Country (2027-2032) & (US$/unit) Table 209. Germany Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 210. France Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 211. U.K. Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 212. Italy Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 213. Russia Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 214. Spain Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 215. Netherlands Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 216. Switzerland Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 217. Sweden Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 218. Poland Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 219. China Immune Health Ingredient Revenue by Type (2021-2026) & (US$ Million) Table 220. China Immune Health Ingredient Revenue by Type (2027-2032) & (US$ Million) Table 221. China Immune Health Ingredient Sales by Type (2021-2026) & (k units) Table 222. China Immune Health Ingredient Sales by Type (2027-2032) & (k units) Table 223. China Immune Health Ingredient Sales Price by Type (2021-2026) & (US$/unit) Table 224. China Immune Health Ingredient Sales Price by Type (2027-2032) & (US$/unit) Table 225. China Immune Health Ingredient Revenue by Application (2021-2026) & (US$ Million) Table 226. China Immune Health Ingredient Revenue by Application (2027-2032) & (US$ Million) Table 227. China Immune Health Ingredient Sales by Application (2021-2026) & (k units) Table 228. China Immune Health Ingredient Sales by Application (2027-2032) & (k units) Table 229. China Immune Health Ingredient Sales Price by Application (2021-2026) & (US$/unit) Table 230. China Immune Health Ingredient Sales Price by Application (2027-2032) & (US$/unit) Table 231. Asia Immune Health Ingredient Revenue by Type (2021-2026) & (US$ Million) Table 232. Asia Immune Health Ingredient Revenue by Type (2027-2032) & (US$ Million) Table 233. Asia Immune Health Ingredient Sales by Type (2021-2026) & (k units) Table 234. Asia Immune Health Ingredient Sales by Type (2027-2032) & (k units) Table 235. Asia Immune Health Ingredient Sales Price by Type (2021-2026) & (US$/unit) Table 236. Asia Immune Health Ingredient Sales Price by Type (2027-2032) & (US$/unit) Table 237. Asia Immune Health Ingredient Revenue by Application (2021-2026) & (US$ Million) Table 238. Asia Immune Health Ingredient Revenue by Application (2027-2032) & (US$ Million) Table 239. Asia Immune Health Ingredient Sales by Application (2021-2026) & (k units) Table 240. Asia Immune Health Ingredient Sales by Application (2027-2032) & (k units) Table 241. Asia Immune Health Ingredient Sales Price by Application (2021-2026) & (US$/unit) Table 242. Asia Immune Health Ingredient Sales Price by Application (2027-2032) & (US$/unit) Table 243. Asia Immune Health Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 244. Asia Immune Health Ingredient Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 245. Asia Immune Health Ingredient Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 246. Asia Immune Health Ingredient Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 247. Asia Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 248. Asia Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 249. Asia Immune Health Ingredient Sales Price by Country (2021-2026) & (US$/unit) Table 250. Asia Immune Health Ingredient Sales Price by Country (2027-2032) & (US$/unit) Table 251. Japan Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 252. South Korea Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 253. India Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 254. Australia Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 255. Taiwan Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 256. Southeast Asia Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 257. SAMEA Immune Health Ingredient Revenue by Type (2021-2026) & (US$ Million) Table 258. SAMEA Immune Health Ingredient Revenue by Type (2027-2032) & (US$ Million) Table 259. SAMEA Immune Health Ingredient Sales by Type (2021-2026) & (k units) Table 260. SAMEA Immune Health Ingredient Sales by Type (2027-2032) & (k units) Table 261. SAMEA Immune Health Ingredient Sales Price by Type (2021-2026) & (US$/unit) Table 262. SAMEA Immune Health Ingredient Sales Price by Type (2027-2032) & (US$/unit) Table 263. SAMEA Immune Health Ingredient Revenue by Application (2021-2026) & (US$ Million) Table 264. SAMEA Immune Health Ingredient Revenue by Application (2027-2032) & (US$ Million) Table 265. SAMEA Immune Health Ingredient Sales by Application (2021-2026) & (k units) Table 266. SAMEA Immune Health Ingredient Sales by Application (2027-2032) & (k units) Table 267. SAMEA Immune Health Ingredient Sales Price by Application (2021-2026) & (US$/unit) Table 268. SAMEA Immune Health Ingredient Sales Price by Application (2027-2032) & (US$/unit) Table 269. SAMEA Immune Health Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 270. SAMEA Immune Health Ingredient Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 271. SAMEA Immune Health Ingredient Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 272. SAMEA Immune Health Ingredient Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 273. SAMEA Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 274. SAMEA Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 275. SAMEA Immune Health Ingredient Sales Price by Country (2021-2026) & (US$/unit) Table 276. SAMEA Immune Health Ingredient Sales Price by Country (2027-2032) & (US$/unit) Table 277. Brazil Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 278. Argentina Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 279. Chile Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 280. Colombia Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 281. Peru Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 282. Saudi Arabia Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 283. Israel Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 284. UAE Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 285. Turkey Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 286. Iran Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 287. Egypt Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Table 288. Key Raw Materials Table 289. Raw Materials Key Suppliers Table 290. Immune Health Ingredient Distributors List Table 291. Immune Health Ingredient Customers List Table 292. Research Programs/Design for This Report Table 293. Authors List of This Report Table 294. Secondary Sources Table 295. Primary Sources List of Figures Figure 1. Immune Health Ingredient Image Figure 2. Global Immune Health Ingredient Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Health Ingredient Market Size Share 2021 VS 2025 VS 2032 Figure 4. Plant & Fruit Extracts Image Figure 5. Nutritional Lipids Image Figure 6. Prebiotics Image Figure 7. Probiotic Starter Cultures Image Figure 8. Vitamins Image Figure 9. Minerals Image Figure 10. Enzymes Image Figure 11. Functional Carbohydrates Image Figure 12. Proteins Image Figure 13. Global Immune Health Ingredient Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Immune Health Ingredient Market Size Share 2021 VS 2025 VS 2032 Figure 15. Beverages Image Figure 16. Pharmaceuticals Image Figure 17. Feed Image Figure 18. Food Image Figure 19. Others Image Figure 20. Global Immune Health Ingredient Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Figure 22. Global Immune Health Ingredient Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Immune Health Ingredient Revenue Market Share by Region: 2025 Versus 2032 Figure 24. Global Immune Health Ingredient Revenue Market Share by Region (2021-2032) Figure 25. Global Immune Health Ingredient Sales (2021-2032) & (k units) Figure 26. Global Immune Health Ingredient Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Immune Health Ingredient Sales Market Share by Region (2021-2032) Figure 28. US & Canada & Mexico Immune Health Ingredient Sales YoY (2021-2032) & (k units) Figure 29. Europe Immune Health Ingredient Sales YoY (2021-2032) & (k units) Figure 30. China Immune Health Ingredient Sales YoY (2021-2032) & (k units) Figure 31. Asia (Excluding China) Immune Health Ingredient Sales YoY (2021-2032) & (k units) Figure 32. South America, Middle East and Africa Immune Health Ingredient Sales YoY (2021-2032) & (k units) Figure 33. Global Immune Health Ingredient Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 34. Global Immune Health Ingredient Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 35. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. Global Immune Health Ingredient Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Immune Health Ingredient Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Immune Health Ingredient Revenue Market Share by Type (2021-2032) Figure 39. Global Immune Health Ingredient Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Immune Health Ingredient Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 41. Global Immune Health Ingredient Sales Market Share by Type (2021-2032) Figure 42. Global Immune Health Ingredient Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 43. Global Immune Health Ingredient Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Immune Health Ingredient Revenue Market Share by Application (2021-2032) Figure 45. Global Immune Health Ingredient Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 46. Global Immune Health Ingredient Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 47. Global Immune Health Ingredient Sales Market Share by Application (2021-2032) Figure 48. North America Immune Health Ingredient Revenue Share by Type (2021-2032) Figure 49. North America Immune Health Ingredient Sales Share by Type (2021-2032) Figure 50. North America Immune Health Ingredient Revenue Share by Application (2021-2032) Figure 51. North America Immune Health Ingredient Sales Share by Application (2021-2032) Figure 52. North America Immune Health Ingredient Revenue Share by Country (2021-2032) Figure 53. North America Immune Health Ingredient Sales Share by Country (2021-2032) Figure 54. Europe Immune Health Ingredient Revenue Share by Type (2021-2032) Figure 55. Europe Immune Health Ingredient Sales Share by Type (2021-2032) Figure 56. Europe Immune Health Ingredient Revenue Share by Application (2021-2032) Figure 57. Europe Immune Health Ingredient Sales Share by Application (2021-2032) Figure 58. Europe Immune Health Ingredient Revenue Share by Country (2021-2032) Figure 59. Europe Immune Health Ingredient Sales Share by Country (2021-2032) Figure 60. China Immune Health Ingredient Revenue Share by Type (2021-2032) Figure 61. China Immune Health Ingredient Sales Share by Type (2021-2032) Figure 62. China Immune Health Ingredient Revenue Share by Application (2021-2032) Figure 63. China Immune Health Ingredient Sales Share by Application (2021-2032) Figure 64. Asia Immune Health Ingredient Revenue Share by Type (2021-2032) Figure 65. Asia Immune Health Ingredient Sales Share by Type (2021-2032) Figure 66. Asia Immune Health Ingredient Revenue Share by Application (2021-2032) Figure 67. Asia Immune Health Ingredient Sales Share by Application (2021-2032) Figure 68. Asia Immune Health Ingredient Revenue Share by Country (2021-2032) Figure 69. Asia Immune Health Ingredient Sales Share by Country (2021-2032) Figure 70. SAMEA Immune Health Ingredient Revenue Share by Type (2021-2032) Figure 71. SAMEA Immune Health Ingredient Sales Share by Type (2021-2032) Figure 72. SAMEA Immune Health Ingredient Revenue Share by Application (2021-2032) Figure 73. SAMEA Immune Health Ingredient Sales Share by Application (2021-2032) Figure 74. SAMEA Immune Health Ingredient Revenue Share by Country (2021-2032) Figure 75. SAMEA Immune Health Ingredient Sales Share by Country (2021-2032) Figure 76. Immune Health Ingredient Value Chain Figure 77. Manufacturing Cost Structure Figure 78. Immune Health Ingredient Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Plant & Fruit Extracts
  • Nutritional Lipids
  • Prebiotics
  • Probiotic Starter Cultures
  • Vitamins
  • Minerals
  • Enzymes
  • Functional Carbohydrates
  • Proteins
Applications
  • Beverages
  • Pharmaceuticals
  • Feed
  • Food
  • Others
Companies covered
  • ADM
  • Arla Foods
  • Associated British Foods
  • Balchem
  • Cargill
  • Chr. Hansen
  • Divis Laboratories
  • DSM
  • Glanbia PLC
  • Ingredion
  • International Flavors & Fragrances
  • Kerry Group PLC
  • MartinBauer
  • Roquette
  • ROYAL FRIESLANDCAMPINA N.V.
  • Tate & Lyle
  • BASF
  • Fonterra
  • Lonza
  • Probi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Immune Health Ingredient Market by Type
  3. 1.2.1 Global Immune Health Ingredient Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Plant & Fruit Extracts
  5. 1.2.3 Nutritional Lipids
  6. 1.2.4 Prebiotics
  7. 1.2.5 Probiotic Starter Cultures
  8. 1.2.6 Vitamins
  9. 1.2.7 Minerals
  10. 1.2.8 Enzymes
  11. 1.2.9 Functional Carbohydrates
  12. 1.2.10 Proteins
  13. 1.3 Immune Health Ingredient Market by Application
  14. 1.3.1 Global Immune Health Ingredient Market Size by Application, 2021 VS 2025 VS 2032
  15. 1.3.2 Beverages
  16. 1.3.3 Pharmaceuticals
  17. 1.3.4 Feed
  18. 1.3.5 Food
  19. 1.3.6 Others
  20. 1.4 Assumptions and Limitations
  21. 1.5 Study Goals and Objectives
2 Immune Health Ingredient Market Dynamics
  1. 2.1 Immune Health Ingredient Industry Trends
  2. 2.2 Immune Health Ingredient Industry Drivers
  3. 2.3 Immune Health Ingredient Industry Opportunities and Challenges
  4. 2.4 Immune Health Ingredient Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Immune Health Ingredient Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Immune Health Ingredient Revenue by Region
  3. 3.2.1 Global Immune Health Ingredient Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Immune Health Ingredient Revenue by Region (2021-2026)
  5. 3.2.3 Global Immune Health Ingredient Revenue by Region (2027-2032)
  6. 3.2.4 Global Immune Health Ingredient Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Immune Health Ingredient Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Immune Health Ingredient Sales by Region
  9. 3.4.1 Global Immune Health Ingredient Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Immune Health Ingredient Sales by Region (2021-2026)
  11. 3.4.3 Global Immune Health Ingredient Sales by Region (2027-2032)
  12. 3.4.4 Global Immune Health Ingredient Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Immune Health Ingredient Revenue by Manufacturers
  2. 4.1.1 Global Immune Health Ingredient Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Immune Health Ingredient Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Immune Health Ingredient Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Immune Health Ingredient Sales by Manufacturers
  6. 4.2.1 Global Immune Health Ingredient Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Immune Health Ingredient Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Immune Health Ingredient Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Immune Health Ingredient Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Immune Health Ingredient Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Immune Health Ingredient Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Immune Health Ingredient Manufacturers, Product Type & Application
  13. 4.7 Global Immune Health Ingredient Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Immune Health Ingredient Market CR5 and HHI
  16. 4.8.2 2025 Immune Health Ingredient Tier 1, Tier 2, and Tier 3
5 Immune Health Ingredient Market by Type
  1. 5.1 Global Immune Health Ingredient Revenue by Type
  2. 5.1.1 Global Immune Health Ingredient Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Immune Health Ingredient Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Immune Health Ingredient Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Immune Health Ingredient Sales by Type
  6. 5.2.1 Global Immune Health Ingredient Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immune Health Ingredient Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Immune Health Ingredient Sales Market Share by Type (2021-2032)
  9. 5.3 Global Immune Health Ingredient Price by Type
6 Immune Health Ingredient Market by Application
  1. 6.1 Global Immune Health Ingredient Revenue by Application
  2. 6.1.1 Global Immune Health Ingredient Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Immune Health Ingredient Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Immune Health Ingredient Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Immune Health Ingredient Sales by Application
  6. 6.2.1 Global Immune Health Ingredient Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Immune Health Ingredient Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Immune Health Ingredient Sales Market Share by Application (2021-2032)
  9. 6.3 Global Immune Health Ingredient Price by Application
7 Company Profiles
  1. 7.1 ADM
  2. 7.1.1 ADM Company Information
  3. 7.1.2 ADM Business Overview
  4. 7.1.3 ADM Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ADM Immune Health Ingredient Product Portfolio
  6. 7.1.5 ADM Recent Developments
  7. 7.2 Arla Foods
  8. 7.2.1 Arla Foods Company Information
  9. 7.2.2 Arla Foods Business Overview
  10. 7.2.3 Arla Foods Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Arla Foods Immune Health Ingredient Product Portfolio
  12. 7.2.5 Arla Foods Recent Developments
  13. 7.3 Associated British Foods
  14. 7.3.1 Associated British Foods Company Information
  15. 7.3.2 Associated British Foods Business Overview
  16. 7.3.3 Associated British Foods Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Associated British Foods Immune Health Ingredient Product Portfolio
  18. 7.3.5 Associated British Foods Recent Developments
  19. 7.4 Balchem
  20. 7.4.1 Balchem Company Information
  21. 7.4.2 Balchem Business Overview
  22. 7.4.3 Balchem Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Balchem Immune Health Ingredient Product Portfolio
  24. 7.4.5 Balchem Recent Developments
  25. 7.5 Cargill
  26. 7.5.1 Cargill Company Information
  27. 7.5.2 Cargill Business Overview
  28. 7.5.3 Cargill Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cargill Immune Health Ingredient Product Portfolio
  30. 7.5.5 Cargill Recent Developments
  31. 7.6 Chr. Hansen
  32. 7.6.1 Chr. Hansen Company Information
  33. 7.6.2 Chr. Hansen Business Overview
  34. 7.6.3 Chr. Hansen Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Chr. Hansen Immune Health Ingredient Product Portfolio
  36. 7.6.5 Chr. Hansen Recent Developments
  37. 7.7 Divis Laboratories
  38. 7.7.1 Divis Laboratories Company Information
  39. 7.7.2 Divis Laboratories Business Overview
  40. 7.7.3 Divis Laboratories Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Divis Laboratories Immune Health Ingredient Product Portfolio
  42. 7.7.5 Divis Laboratories Recent Developments
  43. 7.8 DSM
  44. 7.8.1 DSM Company Information
  45. 7.8.2 DSM Business Overview
  46. 7.8.3 DSM Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 DSM Immune Health Ingredient Product Portfolio
  48. 7.8.5 DSM Recent Developments
  49. 7.9 Glanbia PLC
  50. 7.9.1 Glanbia PLC Company Information
  51. 7.9.2 Glanbia PLC Business Overview
  52. 7.9.3 Glanbia PLC Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Glanbia PLC Immune Health Ingredient Product Portfolio
  54. 7.9.5 Glanbia PLC Recent Developments
  55. 7.10 Ingredion
  56. 7.10.1 Ingredion Company Information
  57. 7.10.2 Ingredion Business Overview
  58. 7.10.3 Ingredion Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ingredion Immune Health Ingredient Product Portfolio
  60. 7.10.5 Ingredion Recent Developments
  61. 7.11 International Flavors & Fragrances
  62. 7.11.1 International Flavors & Fragrances Company Information
  63. 7.11.2 International Flavors & Fragrances Business Overview
  64. 7.11.3 International Flavors & Fragrances Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 International Flavors & Fragrances Immune Health Ingredient Product Portfolio
  66. 7.11.5 International Flavors & Fragrances Recent Developments
  67. 7.12 Kerry Group PLC
  68. 7.12.1 Kerry Group PLC Company Information
  69. 7.12.2 Kerry Group PLC Business Overview
  70. 7.12.3 Kerry Group PLC Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Kerry Group PLC Immune Health Ingredient Product Portfolio
  72. 7.12.5 Kerry Group PLC Recent Developments
  73. 7.13 MartinBauer
  74. 7.13.1 MartinBauer Company Information
  75. 7.13.2 MartinBauer Business Overview
  76. 7.13.3 MartinBauer Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 MartinBauer Immune Health Ingredient Product Portfolio
  78. 7.13.5 MartinBauer Recent Developments
  79. 7.14 Roquette
  80. 7.14.1 Roquette Company Information
  81. 7.14.2 Roquette Business Overview
  82. 7.14.3 Roquette Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Roquette Immune Health Ingredient Product Portfolio
  84. 7.14.5 Roquette Recent Developments
  85. 7.15 ROYAL FRIESLANDCAMPINA N.V.
  86. 7.15.1 ROYAL FRIESLANDCAMPINA N.V. Company Information
  87. 7.15.2 ROYAL FRIESLANDCAMPINA N.V. Business Overview
  88. 7.15.3 ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Product Portfolio
  90. 7.15.5 ROYAL FRIESLANDCAMPINA N.V. Recent Developments
  91. 7.16 Tate & Lyle
  92. 7.16.1 Tate & Lyle Company Information
  93. 7.16.2 Tate & Lyle Business Overview
  94. 7.16.3 Tate & Lyle Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Tate & Lyle Immune Health Ingredient Product Portfolio
  96. 7.16.5 Tate & Lyle Recent Developments
  97. 7.17 BASF
  98. 7.17.1 BASF Company Information
  99. 7.17.2 BASF Business Overview
  100. 7.17.3 BASF Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 BASF Immune Health Ingredient Product Portfolio
  102. 7.17.5 BASF Recent Developments
  103. 7.18 Fonterra
  104. 7.18.1 Fonterra Company Information
  105. 7.18.2 Fonterra Business Overview
  106. 7.18.3 Fonterra Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Fonterra Immune Health Ingredient Product Portfolio
  108. 7.18.5 Fonterra Recent Developments
  109. 7.19 Lonza
  110. 7.19.1 Lonza Company Information
  111. 7.19.2 Lonza Business Overview
  112. 7.19.3 Lonza Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Lonza Immune Health Ingredient Product Portfolio
  114. 7.19.5 Lonza Recent Developments
  115. 7.20 Probi
  116. 7.20.1 Probi Company Information
  117. 7.20.2 Probi Business Overview
  118. 7.20.3 Probi Immune Health Ingredient Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Probi Immune Health Ingredient Product Portfolio
  120. 7.20.5 Probi Recent Developments
8 North America
  1. 8.1 North America Immune Health Ingredient Market Size by Type
  2. 8.1.1 North America Immune Health Ingredient Revenue by Type (2021-2032)
  3. 8.1.2 North America Immune Health Ingredient Sales by Type (2021-2032)
  4. 8.1.3 North America Immune Health Ingredient Price by Type (2021-2032)
  5. 8.2 North America Immune Health Ingredient Market Size by Application
  6. 8.2.1 North America Immune Health Ingredient Revenue by Application (2021-2032)
  7. 8.2.2 North America Immune Health Ingredient Sales by Application (2021-2032)
  8. 8.2.3 North America Immune Health Ingredient Price by Application (2021-2032)
  9. 8.3 North America Immune Health Ingredient Market Size by Country
  10. 8.3.1 North America Immune Health Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Immune Health Ingredient Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Immune Health Ingredient Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Immune Health Ingredient Market Size by Type
  2. 9.1.1 Europe Immune Health Ingredient Revenue by Type (2021-2032)
  3. 9.1.2 Europe Immune Health Ingredient Sales by Type (2021-2032)
  4. 9.1.3 Europe Immune Health Ingredient Price by Type (2021-2032)
  5. 9.2 Europe Immune Health Ingredient Market Size by Application
  6. 9.2.1 Europe Immune Health Ingredient Revenue by Application (2021-2032)
  7. 9.2.2 Europe Immune Health Ingredient Sales by Application (2021-2032)
  8. 9.2.3 Europe Immune Health Ingredient Price by Application (2021-2032)
  9. 9.3 Europe Immune Health Ingredient Market Size by Country
  10. 9.3.1 Europe Immune Health Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Immune Health Ingredient Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Immune Health Ingredient Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Immune Health Ingredient Market Size by Type
  2. 10.1.1 China Immune Health Ingredient Revenue by Type (2021-2032)
  3. 10.1.2 China Immune Health Ingredient Sales by Type (2021-2032)
  4. 10.1.3 China Immune Health Ingredient Price by Type (2021-2032)
  5. 10.2 China Immune Health Ingredient Market Size by Application
  6. 10.2.1 China Immune Health Ingredient Revenue by Application (2021-2032)
  7. 10.2.2 China Immune Health Ingredient Sales by Application (2021-2032)
  8. 10.2.3 China Immune Health Ingredient Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Immune Health Ingredient Market Size by Type
  2. 11.1.1 Asia Immune Health Ingredient Revenue by Type (2021-2032)
  3. 11.1.2 Asia Immune Health Ingredient Sales by Type (2021-2032)
  4. 11.1.3 Asia Immune Health Ingredient Price by Type (2021-2032)
  5. 11.2 Asia Immune Health Ingredient Market Size by Application
  6. 11.2.1 Asia Immune Health Ingredient Revenue by Application (2021-2032)
  7. 11.2.2 Asia Immune Health Ingredient Sales by Application (2021-2032)
  8. 11.2.3 Asia Immune Health Ingredient Price by Application (2021-2032)
  9. 11.3 Asia Immune Health Ingredient Market Size by Country
  10. 11.3.1 Asia Immune Health Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Immune Health Ingredient Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Immune Health Ingredient Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Immune Health Ingredient Market Size by Type
  2. 12.1.1 SAMEA Immune Health Ingredient Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Immune Health Ingredient Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Immune Health Ingredient Price by Type (2021-2032)
  5. 12.2 SAMEA Immune Health Ingredient Market Size by Application
  6. 12.2.1 SAMEA Immune Health Ingredient Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Immune Health Ingredient Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Immune Health Ingredient Price by Application (2021-2032)
  9. 12.3 SAMEA Immune Health Ingredient Market Size by Country
  10. 12.3.1 SAMEA Immune Health Ingredient Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Immune Health Ingredient Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Immune Health Ingredient Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Immune Health Ingredient Value Chain Analysis
  2. 13.1.1 Immune Health Ingredient Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Immune Health Ingredient Production Mode & Process
  6. 13.2 Immune Health Ingredient Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Immune Health Ingredient Distributors
  9. 13.2.3 Immune Health Ingredient Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst